Skip to content
OpenCapital
Get started

Integra LifeSciences IART Contract with Customer, Asset, after Allowance for Credit Loss

Contract with Customer, Asset, after Allowance for Credit Loss at other companies

Lumentum Holdings Inc. logo
Lumentum Holdings Inc.LITE
$441.6M+72.7%
Flex Ltd. logo
Flex Ltd.FLEX
$1.06B+72.6%
State Street logo
State StreetSTT
$3.86B+19.5%
Northrop Grumman logo
Northrop GrummanNOC
$6.54B+10.8%
Williams Companies logo
Williams CompaniesWMB
$108M-12.9%
Virtu Financial logo
Virtu FinancialVIRT
$0—

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B+53.4%
Enterprise value$3.12B+21.1%
P/S0.8×+0.3×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%—
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%—
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerAssetNet.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's contract with customer, asset, after allowance for credit loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's contract with customer, asset, after allowance for credit loss?
Integra LifeSciences (IART) reported contract with customer, asset, after allowance for credit loss of $6.66M in Q1 2026.
How has Integra LifeSciences's contract with customer, asset, after allowance for credit loss changed year-over-year?
Integra LifeSciences's contract with customer, asset, after allowance for credit loss increased by 30.1% year-over-year, from $5.12M to $6.66M.
What is the long-term trend for Integra LifeSciences's contract with customer, asset, after allowance for credit loss?
Over 5 years (2020 to 2025), Integra LifeSciences's contract with customer, asset, after allowance for credit loss has grown at a -1.6% compound annual growth rate (CAGR), from $7.43M to $6.84M.